ArticleFrontiers in cardiovascular medicine2023

Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial.

Takuji Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.